SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akebia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – AKBA
- Saturday, March 26, 2022, 7:17
- PR Newswire
- Add a comment
NEW YORK, March 26, 2022 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Akebia Therapeutics, Inc. (“Akebia” or the “Company”) (NASDAQ: AKBA) and certain of its officers. The class action, filed in the United States District Court for the Eastern…
About the Author
admin has written 20655 stories on this site.